| Primary |
| Drug Use For Unknown Indication |
28.7% |
| Product Used For Unknown Indication |
13.5% |
| Percutaneous Coronary Intervention |
12.6% |
| Myocardial Infarction |
9.7% |
| Acute Myocardial Infarction |
7.5% |
| Acute Coronary Syndrome |
5.3% |
| Stent Placement |
3.5% |
| Anticoagulant Therapy |
3.1% |
| Catheterisation Cardiac |
2.5% |
| Coronary Angioplasty |
2.4% |
| Electrocardiogram St Segment Elevation |
1.8% |
| Coronary Arterial Stent Insertion |
1.6% |
| Angioplasty |
1.5% |
| Antiplatelet Therapy |
1.2% |
| Chest Pain |
1.2% |
| Coronary Artery Disease |
0.9% |
| Prophylaxis |
0.9% |
| Arteriogram Coronary |
0.7% |
| Cardiac Operation |
0.7% |
| Coagulopathy |
0.7% |
|
| Thrombocytopenia |
33.6% |
| Platelet Count Decreased |
9.6% |
| Haemorrhage |
9.3% |
| Retroperitoneal Haemorrhage |
7.2% |
| Thrombosis |
6.0% |
| Gastrointestinal Haemorrhage |
3.6% |
| Haemorrhage Intracranial |
3.6% |
| Pulmonary Haemorrhage |
3.6% |
| Cerebrovascular Accident |
2.4% |
| Haemoptysis |
2.4% |
| Overdose |
2.4% |
| Pulmonary Alveolar Haemorrhage |
2.4% |
| Pulmonary Embolism |
2.4% |
| Death |
2.1% |
| Vomiting |
1.8% |
| Renal Failure |
1.5% |
| Tracheal Haemorrhage |
1.5% |
| Tremor |
1.5% |
| Uterine Leiomyoma |
1.5% |
| Ventricular Tachycardia |
1.5% |
|
| Secondary |
| Drug Use For Unknown Indication |
31.8% |
| Product Used For Unknown Indication |
19.2% |
| Myocardial Infarction |
10.7% |
| Catheterisation Cardiac |
6.8% |
| Percutaneous Coronary Intervention |
3.8% |
| Stent Placement |
2.9% |
| Acute Myocardial Infarction |
2.9% |
| Angioplasty |
2.8% |
| Coronary Arterial Stent Insertion |
2.3% |
| Chest Pain |
2.2% |
| Arteriogram Coronary |
2.0% |
| Cardiac Ventriculogram Left |
2.0% |
| Coronary Artery Disease |
2.0% |
| Acute Coronary Syndrome |
1.9% |
| Prophylaxis |
1.7% |
| Anticoagulant Therapy |
1.4% |
| Antiplatelet Therapy |
1.0% |
| Hypertension |
1.0% |
| Electrocardiogram St Segment Elevation |
0.9% |
| Intracardiac Thrombus |
0.7% |
|
| Thrombosis |
12.6% |
| Tachypnoea |
12.0% |
| Thrombocytopenia |
10.9% |
| Unresponsive To Stimuli |
10.3% |
| Vomiting |
8.6% |
| Vascular Pseudoaneurysm |
6.9% |
| Platelet Count Decreased |
5.1% |
| Thrombosis In Device |
4.0% |
| Cerebral Haemorrhage |
3.4% |
| Death |
3.4% |
| Tachycardia |
3.4% |
| Coronary Artery Thrombosis |
2.9% |
| Haemorrhage Intracranial |
2.9% |
| Haemoptysis |
2.3% |
| Pulmonary Alveolar Haemorrhage |
2.3% |
| Pulmonary Embolism |
2.3% |
| Haemodynamic Instability |
1.7% |
| Haemorrhage |
1.7% |
| Melaena |
1.7% |
| Overdose |
1.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
39.2% |
| Drug Use For Unknown Indication |
10.7% |
| Coronary Artery Bypass |
6.9% |
| Acute Myocardial Infarction |
6.3% |
| Prophylaxis |
6.2% |
| Acute Coronary Syndrome |
5.9% |
| Hypertension |
4.5% |
| Catheterisation Cardiac |
3.1% |
| Percutaneous Coronary Intervention |
2.7% |
| Pain |
2.1% |
| Myocardial Infarction |
1.8% |
| Gastrooesophageal Reflux Disease |
1.6% |
| Stent Placement |
1.5% |
| Hypercholesterolaemia |
1.4% |
| Anticoagulant Therapy |
1.3% |
| Type 2 Diabetes Mellitus |
1.3% |
| Osteoporosis |
1.1% |
| Antiplatelet Therapy |
0.9% |
| Metastases To Bone |
0.9% |
| Coronary Artery Disease |
0.8% |
|
| Thrombosis In Device |
14.1% |
| Unevaluable Event |
11.9% |
| Injury |
7.9% |
| Pain |
7.9% |
| Long Qt Syndrome |
6.8% |
| Fear |
5.6% |
| Walking Aid User |
5.1% |
| Emotional Distress |
4.5% |
| Anxiety |
4.0% |
| Myocardial Infarction |
4.0% |
| Renal Failure |
4.0% |
| Vascular Pseudoaneurysm |
4.0% |
| Vomiting |
4.0% |
| Hypotension |
2.8% |
| Nervousness |
2.8% |
| Anhedonia |
2.3% |
| Haemorrhage Intracranial |
2.3% |
| Pain In Extremity |
2.3% |
| Thrombocytopenia |
2.3% |
| Catheter Related Complication |
1.7% |
|
| Interacting |
| Acute Myocardial Infarction |
64.7% |
| Osteoporosis |
23.5% |
| Stent Embolisation |
11.8% |
|
| Drug Interaction |
33.3% |
| Gastrointestinal Haemorrhage |
33.3% |
| Pulmonary Haemorrhage |
33.3% |
|
